Skip to main content
Watch Insiders
ALXOHealthcare

Alx Oncology Holdings Inc (ALXO) Insider Trading

In the last 90 days, 2 Alx Oncology Holdings Inc (ALXO) insiders reported no open-market purchases and 2 sales totaling $5,410. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 17, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 17, 2026Jason LettmannCHIEF EXECUTIVE OFFICERSale2,230$1.93$4,304
Aug 17, 2026Shelly WongSVP, FINANCE AND CAOSale573$1.93$1,106
Jul 1, 2026Shelly WongSVP, FINANCE AND CAOSale1,404$2.04$2,864

Common questions

ALXO insider trading FAQ

Are ALXO insiders buying or selling?
Over the last 90 days, ALXO insiders were net sellers, reporting $0.00 of open-market purchases and $5,410 of sales.
When was the last ALXO insider purchase?
No open-market insider purchase of Alx Oncology Holdings Inc stock was reported in the last 90 days.
Where does ALXO insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Alx Oncology Holdings Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.